Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Routine HAART for PMTCT in Rural Zambia
NCT00753324Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2009
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of zidovudine, lamivudine, nevirapine, lopinavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: HIV Infection at 12 months. Started May 2009; status: completed.
02
Drugs
zidovudinelamivudinenevirapinelopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00753324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753324.